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Abstract: Salvadora persica L. (S. persica, Siwak) is an ethnic plant that is widely used for improving
oral hygiene. This study aimed to provide a phytochemical profiling of S. persica ethyl acetate fraction
(SPEAF) and to evaluate the healing activity of a muco-adhesive formula of the fraction against acetic
acid-induced oral ulcers in rats. HPLC-ESI-QTOF-MS-MS analysis of SPEAF resulted in the tentative
identification of 56 metabolites containing fatty acids (23%), urea derivatives (10.5%) and sulphur
compounds (10%), in addition to several amides, polyphenols and organic acids (6.5%, 5% and 2%,
respectively). For the first time, 19 compounds were identified from S. persica. In vitro and in vivo
experiments indicated that the extract is non-toxic. SPEAF exhibited superior healing activities
compared to both the negative and positive control groups on days 7 and 14 of tongue ulcer induction.
This was confirmed by histopathological examinations of haematoxylin and eosin-stained (H&E) and
Masson’s trichrome-stained tongue sections. Moreover, SPEAF showed potent anti-inflammatory
activities, as evidenced by the inhibited expression of interleukin-6 (IL-6) and tumour necrosis alpha
(TNF-α). Moreover, SPEAF exhibited potent antioxidant activity, as it prevented malondialdehyde
(MDA) accumulation, reduced glutathione (GSH) depletion and superoxide dismutase (SOD) exhaustion. SPEAF significantly enhanced hydroxyproline tongue content and upregulated collagen
type I alpha 1 (Col1A1) mRNA expression. SPEAF also improved angiogenesis, as shown by the
increased mRNA expression of the angiopoietin-1 (Ang-1). In conclusion, S. persica has a wide range
of secondary metabolites and ameliorates acetic acid-induced tongue ulcers in rats. This can be
attributed, at least partly, to its anti-inflammatory, antioxidant, procollagen and angiogenic activities.
These findings provide support and validity for the use of S. persica as a traditional and conventional
treatment for oral disorders.
Keywords: Salvadora persica L.; HPLC-ESI-QTOF-MS-MS analysis; anti-inflammatory; antioxidant;
angiogenesis; oral ulcer; wound healing
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1. Introduction
Several diseases of known and unknown aetiology can cause recurrent intraoral mucosal ulceration. Oral ulceration can be benign conditions, such as aphthae, herpetiform,
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erosive lichen planus, benign mucous membrane pemphigoid, allergy, infection, candidiasis, streptococcal stomatitis, histoplasmosis and acute necrotising ulcerative gingivitis, or
conditions with a potential for a severe course, such as pemphigus vulgaris, lupus erythematosus, cyclic neutropenia neoplasm, Behcet’s disease and erythema multiforme [1,2].
Oral ulceration has been linked to a wide range of systemic medicines, with clinical
manifestations ranging from superficial, nonspecific ulcerations to aphthous-like lesions or
widespread mucosal erosions [3]. Nicorandil [4,5], captopril [6] and some nonsteroidal antiinflammatory medicines can produce aphthous-like and nonspecific oral ulcers [7]. Oral
ulcers can be classified as acute or chronic depending on their presentation and progress,
with chronic ulcers lasting more than 14 days. [2].
Therapeutic options for the treatment of recurrent aphthous stomatitis include topical
medications, antiseptics, analgesics, corticosteroids and antibiotics. In addition to systemic
medication, immunomodulators have been reported [3]. Thalidomide is a tumour necrosis
alpha (TNF-α) inhibitor with anti-inflammatory activity. However, due to teratogenic
and other side effects (e.g., irreversible polyneuropathy), its use has been restricted [8].
The possible use of biological agents (e.g., infliximab) as anti-TNF-α therapy for recurrent
aphthae in Behcet’s illness has also been documented [9].
Wound healing is a complex process involving haemostasis, inflammation, proliferation and tissue remodelling [10]. Many phyto-therapeutic studies have been conducted
on oral antiulcerogenic activity based on haemostasis [11]; antioxidant [12–14], antibacterial [15] and anti-inflammatory activities [11,16–19]; proliferation/angiogenesis [20]; and
remodelling phase/re-epithelialisation [11].
Salvadora persica L. Salvadoraceae (Siwak, S. persica) is a plant that has been used for
many centuries as an oral hygiene tool, particularly in Saudi Arabia. Using Siwak (tooth
stick) to clean the mouth is a well-established Islamic belief [21]. S. persica has been shown
to have anti-gingivitis, anti-plaque and anti-cariogenic properties; gingival wound healing
property; whitening capability; orthodontic chain preservation capability; and biocompatibility with oral cells in many investigations. S. persica in various forms has helped
manage and treat oral health [22]. Comprehensive phytochemical investigations have
revealed the presence of carbohydrates, flavonoids, terpenes, sterols, alkaloids, glycosides,
organic sulphur compounds, elemental sulphur and small amounts of fluoride, calcium,
phosphorus, silica and ascorbic acid [21,23].
Oral ulcers heal through the same phases as cutaneous wounds, but there are some
differences, such as the wet external environment, the presence of saliva and various cell
morphologies [24]. The environment of oral ulcers directs drug delivery to the application
of muco-adhesive formulation [25,26]. In light of the research cited, this study prepared a
fraction of S. persica, which has potential wound healing activity, in chemically induced
tongue ulcers in rats and explored its components by using HPLC/MS/MS analysis.
2. Materials and Methods
2.1. Plant Material
S. persica sticks were bought from Riyadh, Saudi Arabia. The plant was identified
by Dr. Talal Dahan, assistant professor of plant classification at Bisha University, Saudi
Arabia. A voucher specimen (No. PG005) was deposited in properly labelled polythene
bags for future reference at Department of Pharmacognosy, Faculty of Pharmacy, The
British University in Egypt, Egypt. The authors followed the IUCN Policy Statement on
Research Involving Species at Risk of Extinction.
2.2. Animals
Fifty male Wistar rats (200–225 g) were used for the study, courtesy of the Animal
Facility, Faculty of Pharmacy, King Abdulaziz University (KAU), Saudi Arabia. The animals
were kept on a 12 h light–dark cycle and a controlled temperature of 22 ± 2 ◦ C. The research
ethics committee of the Faculty of Pharmacy, King Abdulaziz University (KAU), officially
approved experimental protocols (Reference # PH-1443-22).
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2.3. Chemicals
All solvents were of analytical grade, while those used in UPLC/PDA/ESI/MS assays
were of HPLC grade. Carboxymethyl cellulose (CMC) was obtained from Sigma-Aldrich
(Taufkirchen, Germany).
2.4. Preparation of S. persica Ethyl Acetate Fraction (SPEAF)
Fresh plant sticks of S. persica were freeze-dried (laboratory freeze dryer VaCo 5,
ZIRBUS, Bad Grund, Germany) and then ground to a fine powder using a commercially
available food blender. A ground sample (500 g) was used to prepare the fraction. Ethyl
acetate fraction was prepared by cold-percolating 500 g of dried powder of the plant sticks
in 1 L of ethyl acetate for 72 h, and fresh solvent was used every 24 h. This fraction was
prepared after isolating petroleum ether fraction using the same method described above.
The solvent was removed and recovered in a rotary evaporator (Büchi Rotavapor RII; Büchi
Labortechnik, Flawil, Switzerland) at 40 ◦ C using a Büchi vacuum pump to yield 5.4 g
of yellowish-brown powder, which was kept in a brown screw-capped tube in a −20 ◦ C
freezer until further analysis.
2.5. High-Resolution HPLC-ESI-QTOF-MS-MS Analysis
A 6530 QTOF LC/MS (Agilent Technologies) equipped with an autosampler (G7129A),
a quat pump (G7104C) and a column comp (G7116A) was used for chromatographic
separation. The injection volume was 6 µL. The analytes were separated in a Zorbax RP-18
column (Agilent Technologies; dimensions: 150 mm × 3 mm, dp = 2.7 µm) at a flow rate
of 0.230 mL/min. The mobile phase consisted of a combination of solvent A (0.1% formic
acid) and solvent B (acetonitrile + 0.1% formic acid). The gradient elution was as follows:
0–20 min (98–90% A), 20–50 min (90–80% A), 50–70 min (80–50% A), 70–90 min (50–30% A),
90–110 min (30–10% A) and 110–120 min (10–0% A) [27]. Mass spectra were simultaneously
acquired using ESI in (+,−) ionisation modes, with a capillary voltage of 5500 V. The mass
spectra were recorded in the m/z range of 100–1000 m/z. The gas temperature and drying
gas flow were 190 ◦ C and 6 L·/min, respectively. The skimmer and fragmentator voltages
were set to 65 V and 130 V, respectively, and collision energy was 10 V. The nebulisation
pressure was 25 psi g.
Tentative Identification of Metabolites
The tentative identification and analysis of LC-MS-MS of the metabolites of S. persica
were carried out using Sirius® software version 4.7.4 to predict fragmentation and molecular
formulae [28]. The chemical structures were predicted using CSI: FingerID® [29], while
compound classes were predicted directly from MS/MS using CANOPUS® [30].
2.6. Preparation of Plain and Ethyl Acetate Fraction Muco-Adhesive Formulae
In order to prepare the adhesive sponge formula, 2% CMC (w/v) was sprinkled in
distilled water and stirred until homogenous gels formed, as prescribed by [25]. SPEAF
was dissolved in distilled water to a final concentration of 5.0% (w/v) and stirred using a
magnetic stirrer until homogeneous dispersions were achieved. Then, using a magnetic
stirrer, CMC was sprinkled in the previously prepared dispersions until a consistent gel was
achieved. Muco-adhesive property was achieved by the determination of muco-adhesive
time of prepared formulae [25].
2.7. Cytotoxicity Assay
Oral epithelial cells (OEC) were obtained from Nawah Scientific Inc., (Mokatam, Cairo,
Egypt). Cell viability was assessed by SRB assay. Aliquots of 100 µL cell suspension
(5 × 103 cells) were pipetted in 96-well plates and incubated in complete media for 24 h.
Cells were treated with another aliquot of 100 µL media containing SPEAF at various
concentrations. After 72 h of exposure, cells were fixed by replacing media with 150 µL of
10% TCA and incubated at 4 ◦ C for 1 h. The TCA solution was removed, and the cells were
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washed 5 times with distilled water. Aliquots of 70 µL SRB solution (0.4% w/v) were added
and incubated in a dark place at room temperature for 10 min. Plates were washed 3 times
with 1% acetic acid and allowed to air-dry overnight. Then, 150 µL of TRIS (10mM) was
added to dissolve protein-bound SRB stains; the absorbance was measured at 540 nm by
using a BMGLABTECH® -FLUOstar Omega microplate reader (Ortenberg, Germany) [31].
2.8. Acute Oral Toxicity Study
Acute oral toxicity of SPEAF was evaluated in male Wistar rats according to OECD
guideline No. 423. Based on previous pilot studies in our laboratories, a limit test was
performed. Animals were fasted overnight, and SPEAF was administered orally using
gastric feeding needle at a dose of 2000 mg/kg [32].
2.9. Experimental Design
The animals were randomly divided into five groups, with 10 in each group. With the
exception for negative control animals (10 rats), the rats were anaesthetized using ketamine
(50 mg/kg) and xylazine (5 mg/kg). Round filter papers with a diameter of 5.0 mm were
soaked in 15 mL of 50% acetic acid. The acid-soaked filter paper was pressed onto the
inferior surface of the tongue for 60 s [33]. The animals were assigned into five groups,
with 10 in each group, as follows.
Group 1 (negative control): normal rats with no exposure to acetic acid or any treatment.
Group 2 (acetic acid ulcer): acetic acid-challenged animals with no treatment.
Group 3 (ulcer + vehicle): acetic acid ulcer group treated topically once daily with
plain muco-adhesive formulae in the ulcer area.
Group 4 (ulcer + SPEAF): acetic acid ulcer group treated topically once daily with
SPEAF (5% in muco-adhesive formulae) in the ulcer area.
Group 5 (positive control): acetic acid ulcer group treated topically once daily with
Jogel® (Sedico, Giza, Egypt; 10% jojoba oil and 0.5% lidocaine hydrochloride) in the
ulcer area.
All treatments continued for 14 days. On day seven, four animals from each group
were sacrificed by decapitation, and their tongues were dissected and kept in 10% neutral
formalin. On day 14, the rest of the animals in all groups were sacrificed by decapitation,
and their tongues were dissected. One part of the tongues from each animal was kept in
10% neutral formalin, and the other part was flash frozen in liquid nitrogen and kept at
−80 ◦ C for further analysis.
2.10. Histopathological Examination
The excised tongue tissues on days 7 and 14 were fixed in 10% neutral buffered
formalin. They were dehydrated in serial dilutions of ethyl alcohol, immersed in xylene
and embedded in paraffin. On the glass slides, 5-micrometre-thick sections were made.
After dewaxing, the tissue sections were rehydrated. Some sections were stained using
haematoxylin and eosin (H&E), and others were stained with Masson’s trichrome stains.
2.11. Immunohistochemical Staining
The tissue sections were de-paraffinised, rehydrated and boiled in 0.1 M citrate buffer
(pH 6.0) for 10 min. The sections were then kept in 5% bovine serum albumin in Trisbuffered saline (TBS) for 2 h. The tissue sections were then incubated with primary
antibodies to interleukin-6 (IL-6), (Cat. No.: ab9324, Abcam® , Cambridge, UK) and TNF-α
(Cat. No.: ab220210, Abcam® , Cambridge, UK) at 4 ◦ C for 12 h. Following flushing with
TBS, the tissue sections were incubated with either anti-mouse or anti-rabbit biotinylated
secondary antibody according to the primary antibody reactivity (Cell & Tissue Staining
Kit, Cat. No.: CTS002, CTS006, R&D Systems, Minneapolis, MN, USA). Image evaluations
were obtained using Image J (1.52a, National Institutes of Health NIH, Rockville, MD, USA)
with a minimum of three sections per rat.
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2.12. Biochemical Analysis
The tongue tissues were homogenised in a 10-fold volume of ice-cooled phosphatebuffered saline (50 mM potassium phosphate, pH 7.4). The homogenates were centrifuged
for 15 min at 10,000× g and 4 ◦ C, followed by the collection of the supernatant, which was
used for oxidative stress analysis. Commercially available kits were used to assess the liver
content of malondialdehyde (MDA; Cat. No. MD 2529; Biodiagnostic, Giza, Egypt) and
reduced glutathione (GSH; Cat. No. GR 2511; Biodiagnostic, Giza, Egypt) and the enzyme
activities of superoxide dismutase (SOD; Cat. No. SD 2521; Biodiagnostic, Giza, Egypt).
Hydroxyproline was determined using ELISA kits (Cat. No. Ab22294, Abcam, Cambridge,
UK), according to the manufacturer’s instructions.
2.13. RT-qPCR for Collagen Type I Alpha 1 (Col1A1) and Angiopoietin-1 (Ang-1)
Tongue homogenates were subjected to RNA extraction by using a commercially available kit (NucleoSpin, Macherey-Nagel GmbH & Co. KG, Duerin, Germany), followed by
spectrophotometric determination of purity and concentration (dual-wavelength Beckman,
Spectrophotometer, Foster City, California, USA). cDNA was performed using a cDNA
Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). Then, a PCR Master
Mix Kit (Qiagen, Valencia, CA, USA) was used to perform PCR amplification reactions.
The Col1A1 (NM_053304.1) primer and GAPDH (NM_017008.4) as housekeeping genes
were used. The forward/reverse nucleotide sequences of Col1A1, Ang-1 and GAPDH
were 50 -ATCAGCCCAAACCCCAAGGAGA-3/50 -CGCAGGAAGGTCAGCTGGATAG3, 50 -AGGCCCCTCTGAACCCTAAG-3/50 -AGAGGCATACAGGGACAACACA-3 and
50 -CCATTCTTCCACCTTTGATGCT-3/50 -TGTTGCTGTAGCCATATTCATTGT-3, respectively. The data were expressed in the cycle threshold (Ct). The expression of Col1A1
relative to GAPDH was calculated based on the delta–delta Ct (∆∆Ct) values.
2.14. Statistical Analysis
All data were expressed as mean ± SD. The data were analysed using a one-way
analysis of variance and Tukey test. All analyses were performed using GraphPad Prism
software version 8.00 (GraphPad Software, La Jolla, CA, USA). A p value of less than 0.05
was considered statistically significant.
3. Results
3.1. Identification of SPEAF
For the complete phytochemical profiling of the ethyl acetate fraction, a high-resolution
ESI-QTOF-LC-MS-MS analysis was carried out. A total of 56 compounds were detected
and tentatively identified (Table 1), 19 of which were identified in S. persica for the first
time. The majority of the compounds identified were fatty acids (23%), followed by urea
derivatives (10.5%) and sulphur compounds (10%). Several amides, phenolic compounds
and organic acids were also detected at 6.5%, 5% and 2%, respectively. Other individual
minor compounds were detected at 1.5%.
Fifteen different fatty acids were tentatively identified. Palmitic and oleic acids were
the major fatty acids detected; both were identified previously in the stems and roots of
S. persica [34]. Myristic acid (36), hydroxy octadecenoic acid (37), hexadecenoic acid (3),
arachidic acid (40), linoleic acid (41), heptadecenoic acid (44) and stearic acid (54) were
detected previously in the stems and roots of S. persica [23,34], while linolenic acid (35)
was detected previously in the seed oil of S. persica [35]. Hydroxytetradecanoic acid (33),
hydroxyhexadecanoic acid (34), hydroxyoctadecanoic acid (45), nonadecenoic acid (51) and
hydroxyeicosanoic acid (53) were detected in this plant for the first time.
Three urea derivatives were detected in the fraction, and the majority of them consisted
of N,N0 -dibenzyl urea (30, 7.7%), followed by benzyl urea (13, 2.5%) and n-benzyl-N0
hydroxy benzyl urea (25, 0.09%). These compounds were detected and isolated previously
in this species [23,36].
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Four sulphur-containing compounds were also detected. Benzyl isothiocyanate (18)
was the major compound found in the fraction (8.7%); it was detected previously with
O-benzyl hexosyl sulphate (14) in S. persica [23,34]. The molecular formulae of the sulphated
hexosyl phenolic derivative (10) and sulphur compound derivative (32) are C14 H20 O11 S and
C12 H12 N2 O2 S2 , respectively. Both compounds were not detected before in genus Salvadora.
Table 1. LC–MS–MS data of the tentatively identified compounds in SPEAF.
MS2

Molecular
Formula

Error

169.01417

125

C7 H6 O5

6.04

0.43

131.042

—

C5 H8 O4

−1.53

0.67

287.0191

241, 181,
151

C14 H8 O7

−2.08

tr

158.0822

141, 131,
115

C7 H13 O3 N

−0.6

Sugar derivative

0.43

267.1081

221, 153

C10 H20 O8

−0.41

21.2

Methoxy ellagic acid

0.3

315.01459

241, 181,
151

C15 H8 O8

−0.16

7

22.38

Benzamide

1.13

105

C7 H7 NO

−1.15

8

23.95

Salicylic acid

0.73

137.0231

—

C7 H6 O3

−1.28

9

24.69

Diethyl malate

0.7

189.0764

145, 100

C8 H14 O5

−0.46

10

25.4

Sulfated hexosyl
phenolic derivative

0.22

395.0676

315, 241,
153

C14 H20 O11 S

2.22

11

27.067

Methylbenzamide

0.32

—

C8 H9 NO

−7.27

12

27.41

Unknown

1.43

164, 134

C10 H13 NO3

−1.31

13

28.111

Benzyl urea

2.52

—

C8 H10 N2 O

5.89

14

31.31

O-benzyl hexosyl
sulfate

0.42

349.0585

269, 241,
193

C13 H18 O9 S

−3.94

15

32.83

Unknown

0.35

521.2331
(2M − H)

260

C11 H19 NO6

−2.97

16

34.32

Phenolic acid
derivative

0.14

281.13909

151

C15 H22 O5

−1.27

17

34.36

Di-O-methyl ellagic
acid

0.98

329.032

315, 241,
181, 151

C16 H10 O8

5.19

18

35.902

Benzyl isothiocyanate

8.7

—

C8 H7 NS

−5.95

19

37.29

Coumaric acid

tr

163.03897

119

C9 H8 O3

−1.54

20

38.88

Acetyl Phenyl alanine

tr

413.16868
(2M − H)

415.1810
(2M + H)

206, 188

C11 H13 NO3

−7.58

21

47.645

Unknown

1.53

123.0431

—

C5 H4 N3 O

3.15

22

56.8

Ferulic acid

0.39

193.0492

179, 149

C10 H10 O4

−1.74

23

57.55

Methoxy flavanone
hexosyl rhamnoside

0.58

609.18129

463, 301

C28 H34 O15

−1.98

24

59.78

Caffeic acid conjugate

0.13

387.0352

341, 193

C18 H12 O10

−3.41

241, 198,
181, 163

C8 H10 N2 O2

−6.03

#

Retention
Time

1

4.02

2

Area%

MS1 (−ve)

Gallic acid

1.5

10.6

Glutaric acid

3

11.16

Deoxy ellagic acid

4

13.97

Hydroxy stachrydine

5

16.17

6

Compound

N-benzyl-N0

hydroxy

MS1 (+ve)

122.0599

136.0747
194.0809
151.0857

150.0374

25

60.399

26

66.42

Caffeic acid conjugate

0.07

377.18179

341, 161

C17 H30 O9

1.67

27

67.61

Syringin

0.15

371.1344

209

C17 H24 O9

0.51

benzyl urea

0.09

257.1269
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Table 1. Cont.
MS1 (+ve)

MS2

Molecular
Formula

Error

0.15

212.1057

—

C14 H13 NO

−6.08

N-benzyl 2-phenyl
acetamide

0.2

226.1215

—

C15 H15 NO

−5.04

N,N0 dibenzyl urea

7.73

241.1326

181, 163,
108

C15 H18 N2 O

−3.9

74.819

Unknown

0.06

353.1957

—

C19 H28 O6

−1.94

32

75.37

Sulfur compound
derivative

0.61

281.0402

186

33

92.482

Hydroxy tetradecanoic
acid

3.94

487.4005
(2M − H)

243

C14 H28 O3

1.31

34

102.79

Hydroxy
hexadecanoic acid

0.69

543.4565
(2M − H)

271.2266

C16 H32 O3

−0.63

35

106.09

Linolenic acid

1.49

555.4408
(2M − H)

277

C18 H30 O2

−2.01

36

107.327

Myristic acid

0.45

455.4111
(2M − H)

227

C14 H28 O2

1.19

37

108.559

Hydroxy octadecenoic
acid

0.99

595.4890
(2M − H)

297

C18 H34 O3

−8.92

38

109.176

Hexadecenoic acid

0.95

507.4416
(2M − H)

253

C16 H30 O2

−0.64

39

109.35

Unknown

3.09

339.2299

253, 113

C23 H32 O2

−3.05

40

111.332

Arachidic acid

0.12

313.2727

285, 267

C20 H42 O2

4.52

41

111.527

Linoleic acid

2.43

561.4821
(2M + H)

279

C18 H32 O2

−5.52

42

111.552

Fatty acid amide
derivative

0.45

635.5489
(2M + H)

318

C21 H35 NO

−1.89

43

113.309

Fatty acid amide
derivative

0.88

687.5803
(2M + H)

344

C23 H37 NO

−4.5

44

113.598

Heptadecenoic acid

0.29

535.4730
(2M − H)

537.4845
(2M + H)

267

C17 H32 O2

−0.36

45

115.622

Hydroxy octadecanoic
acid

0.54

599.5241
(2M − H)

299

C18 H36 O3

−2.59

46

116.188

Palmitic acid

4.98

511.4714
(2M − H)

513.4861
(2M + H)

255

C16 H32 O2

−2.42

47

116.23

Cholesterol derivative

663.4529

607, 551

C39 H58 N4 O5

5.74

48

117.307

Oleic acid

4.71

565.5175
(2M + H)

281

C18 H34 O2

−2.38

49

118.394

N-benzylpalmitamide

0.06

691.6144
(2M + H)

346

C23 H39 NO

−0.42

50

120.34

N-benzyl
octadecenamide

1.79

743.6433
(2M + H)

372

C25 H41 NO

−0.05

51

121.418

Nonadecenoic acid

0.26

295

C19 H36 O2

−3.79

52

122.592

N-benzyl
heptadecanamide

0.1

360

C24 H41 NO

3.63

#

Retention
Time

28

70.88

N-benzyl benzamide

29

71.663

30

71.7

31

Compound

Area%

MS1 (−ve)

559.4781
(2M − H)

tr
563.5026
(2M − H)

557.4496
(2M + H)

509.4512
(2M + H)

591.5330
(2M − H)
719.6405
(2M + H)

C12 H12 N2 O2 S2 −7.8
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Table 1. Cont.
#

Retention
Time

53

123.163

54

MS2

Molecular
Formula

Error

655.5859
(2M − H)

327

C20 H40 O3

−2.7

567.5334
(2M − H)

283

C18 H36 O2

−3.24

391.2832

167, 149

C24 H38 O4

−5.58

338.3416

321

C22 H43 NO

−0.13

Area%

MS1 (−ve)

Hydroxy eicosanoic
acid

0.73

123.505

Stearic acid

0.31

55

123.666

Diisooctyl phthalate

1.2

56

125.314

13-Docosenamide

1.44

Compound

MS1 (+ve)

Ten amide derivatives were also observed, most of which were amide derivatives
of fatty acids. Compounds n-benzyl benzamide (28), n-benzyl 2-phenyl acetamide (29),
n-benzylpalmitamide (49) and n-benzyl heptadecanamide (52) were identified previously in
S. persica [23,36], while benzamide (7), methylbenzamide (11), fatty acid amide derivatives
(42, 43), n-benzyl octadecenamide (50) and 13-docosenamide (56) were detected in this
plant for the first time.
Regarding phenolic compounds, 11 compounds were detected. All were phenolic
acids and their derivatives, except compound 23 (methoxy flavanone hexosyl rhamnoside),
which is a flavonoid glycoside. With a molecular formula of C15 H22 O5 , compound 16
was detected for the first time in S. persica, and it was tentatively identified as a phenolic
acid derivative. All other phenolic compounds were previously reported in the same
plant [23,37–39]. Three organic acids and their derivatives were identified. Salicylic and
glutaric acids were detected previously in the plant [37,40], whereas compound 9 (diethyl
malate) was detected for the first time in S. persica.
3.2. IC50 of SPEAF on OEC
As shown in Figure 1, IC50 of SPEAF in oral epithelial cells (OEC) was relatively high
(87.5 µg/mL) indicating very weak cytotoxicity of the extract.

Figure 1. IC50 of SPEAF in oral epithelial cells (OEC).
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3.3. Acute Oral Toxicity Study
No mortality was observed in the tested animals at 24 h after oral administration of
2000 mg/kg of SPEAF. The same result was obtained when the test was repeated using three
additional animals at the same dose. According to the Acute Toxic Class Method reported in
OECD guidelines No.423, SPEAF is considered to be Category 5 with LD50 > 2000 mg/kg.
3.4. Histopathological Examination
Microscopic examination of H&E-stained tongue sections from negative control animals on days 7 and 14 showed skeletal muscle arranged in longitudinal and transverse
bundles with a normal histological structure. The tongues were covered by papillae and
stratified squamous epithelium that appeared keratinised on the dorsal surface. The acetic
acid group showed several ulcerative mucosal surfaces, with necrotic areas that extended
to the underlying muscle bundles. Severely dilated blood spaces were commonly observed.
Vehicle-treated animals exhibited ulceration of the epithelial covering layer accompanied by
variable haemorrhages and the accumulation of eosinophilic tissue debris. Dispersions of
muscle bundles with oedema, inflammatory cells and increased number of mast cells were
also observed. SPEAF-treated animals showed obvious protection against acetic acid ulcers.
The mucosal surface appeared normal in several examined sections. A few sections showed
ulcerative epithelial layers, while other sections revealed an aggregation of perivascular
inflammatory cell infiltration. Positive control animals exhibited noticeable protection, as
numerous sections showed marked healing of the ulcerative area, but congested blood
vessels with ulceration were observed in some sections. In order to substantiate these
observations, collagen deposition was assessed by staining sections from all groups using Mason’s trichrome stain. The negative control animals showed normal histological
architecture. The acetic acid group showed tongue sections with a relatively decreased
deposition of collagen fibers. The tongue sections from the SPEAF and positive control
groups exhibited a higher degree of collagen deposition (Figure 2).

Figure 2. Histopathological effects of SPEAF on acetic acid-induced tongue ulcer of rats. SPEAF:
S. persica ethyl acetate fraction. Haematoxylin and Eosin (H&E).
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3.5. Immunohistochemical Assessment of the Expression of Inflammation Markers
The potential of SPEAF as an anti-inflammatory agent was assessed in stressed tongue
tissues. Figure 3 shows that the challenge in tongues with acetic acid was associated with
the enhanced expressions of IL-6 and TNF-α by 176% and 84%, respectively, compared to
corresponding control values. The application of SPEAF significantly reduced IL-6 and
TNF-α expressions by 36% and 24%, respectively, compared to the acetic acid-alone group.
Similarly, the treatment of tongues with the positive control preparation significantly
inhibited IL-6 and TNF-α by 20% and 15%, respectively, compared to the acetic acid
ulcer group.

Figure 3. Effect of SPEAF on expression of inflammation markers in acetic acid-induced tongue ulcer
in rats. Statistical analysis was performed by one-way ANOVA followed by Tukey’s test. a Significant
difference from negative control group at p < 0.05. b Significant difference from acetic acid group at
p < 0.05. c Significant difference from ulcer + vehicle group at p < 0.05. d Significant difference from
Ulcer + SPEAF group at p < 0.05. SPEAF: S. persica ethyl acetate fraction.

3.6. Assessment of Oxidative Status
Figure 4A shows that MDA, a product of polyunsaturated fatty acid peroxidation,
was increased by an acetic acid challenge by 133% of the control value. SPEAF ameliorated
MDA accumulation by 36%. Moreover, acetic acid resulted in GSH depletion compared
to the negative control values. SPEAF and the positive control preparation significantly
ameliorated GSH decrease by 34% and 56%, respectively, compared to the acetic acid group
(Figure 4B). Acetic acid insult was associated with decreased SOD activity. Both SPEAF and
the positive control preparation inhibited SOD exhaustion by 60% and 62%, respectively
(Figure 4C).
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Figure 4. Effect of SPEAF on MDA (A), GSH (B) and SOD (C) in acetic acid-induced tongue ulcer
in rats. Data are presented as mean ± SD (n = 6). Statistical analysis was performed by one-way
ANOVA followed by Tukey’s test. a Significant difference from negative control group at p < 0.05.
b Significant difference from acetic acid group at p < 0.05. c Significant difference from ulcer + vehicle
group at p < 0.05. SPEAF: S. persica ethyl acetate fraction. MDA: malondialdehyde. GSH: glutathione.
SOD: superoxide dismutase.

3.7. Assessment of Collagen Content
Acetic acid-induced tongue ulcers were associated with a significant decrease in
hydroxyproline by 57% compared to the negative control group. The SPEAF group showed
the highest hydroxyproline content, as it was significantly enhanced by 76% compared to
the acetic acid group (Figure 5A). These results were confirmed by assessing the mRNA
expression of Col1A1. Both SPEAF and the positive control preparation significantly
enhanced Col1A1 expression by 64% and 55%, respectively, compared to the acetic acid
group (Figure 5B).
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Figure 5. Effect of SPEAF on hydroxyproline content (A) and Col1A1 expression (B) in acetic acidinduced tongue ulcer in rats. Data are presented as Mean ± SD (n = 6). Statistical analysis was
performed by one-way ANOVA followed by Tukey’s test. a Significant difference from negative
control group at p < 0.05. b Significant difference from acetic acid group at p < 0.05. c Significant
difference from ulcer + vehicle group at p < 0.05. d Significant difference from ulcer + SPEAF group
at p < 0.05. SPEAF: S. persica ethyl acetate fraction.

3.8. Assessment of Ang-1 mRNA Expression
The potential angiogenic activity of SPEAF was assessed in the tongue tissues. Figure 6
shows that SPEAF, and positive control preparation significantly enhanced Ang-1 mRNA
expression by an approximately one-fold increase compared to the acetic acid group.

Figure 6. Effect of SPEAF on Ang-1 mRNA expression in acetic acid-induced tongue ulcer in rats.
Data are presented as mean ± SD (n = 6). Statistical analysis was performed by one-way ANOVA
followed by Tukey’s test. a Significant difference from negative control group at p < 0.05. b Significant
difference from acetic acid group at p < 0.05. c Significant difference from ulcer + Vehicle group at
p < 0.05. SPEAF: S. persica ethyl acetate fraction.
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4. Discussion and Conclusions
Oral ulcers are a common disorder of the oral mucosa. There are many predisposing
conditions, including systemic diseases [41]. The primary treatment of oral ulcers includes
the use of local corticosteroids in addition to antiseptic/anti-inflammatory agents and
local anaesthetics [42]. However, these may have intolerable adverse effects [42,43]. For
this reason, natural products have attracted great attention, as they constituted 16% of
FDA-approved drugs in 2018 [44]. In particular, S. persica is considered to be nature’s
gift for oral health [45,46]. The current study presents a phytochemical profile of SPEAF
using HPLC-ESI-QTOF-MS-MS analysis. Nineteen compounds were detected for the first
time in this plant, 12 of which were tentatively identified as benzamide (7); diethyl malate
(9); methylbenzamide (11); acetyl phenylalanine (20); hydroxytetradecanoic acid (37);
hydroxyhexadecanoic acid (34); hydroxyoctadecanoic acid (45); n-benzyl octadecenamide
(50); nonadecanoic acid (51); hydroxyeicosanoic acid (53); diisooctyl phthalate (55); and
13-docosenamide (56). According to Sirius, compounds 5 and 16 were a sugar derivative
and a phenolic acid derivative, with molecular formulae of C10 H20 O8 and C15 H22 O5 ,
respectively. Compounds 10 and 32 were sulphated compound derivatives, with molecular
formulae of C14 H20 O11 S and C12 H12 N2 O2 S2 , respectively. Compounds 42 (C21 H35 NO) and
43 (C23 H37 NO) were fatty acid amide derivatives, while compound 47 was a cholesterol
derivative, with the molecular formula C39 H58 N4 O5 . Moreover, the healing activity of
a muco-adhesive formula of S. persica against acetic acid-induced oral ulcers in rats was
evaluated for the first time. Our data highlighted the safety of the extract. In addition,
it expedited healing rates in wounded animals. This was confirmed histologically, as
microscopic examinations indicated an almost intact epithelial covering, with fewer signs
of inflammation and enhanced collagen deposition. This is consistent with previously
published experimental data on the wound-healing potential of the plant in the skin or the
tongue [47,48].
The transition from the inflammatory phase to the proliferative phase is a key step
during wound healing [49]. Consequently, if the inflammatory response is extended or
exacerbated, it results in a delay in the subsequent phases of proper wound healing [49,50].
Our results showed that the observed healing activity of S. persica was accompanied by a
shortening of the inflammation phase. This was highlighted by the ability of S. persica in
animal models of peptic ulcer [51] and paw oedema [52]. The effectiveness of S. persica gel
application in the treatment of moderate and deep pockets in patients with periodontitis
was associated with the inhibition of the crevicular fluid IL-6 and TNF-α [52,53]. Flavonoids
have been reported to possess potent anti-inflammatory activity [54]. Based on our phytochemical profiling study, it can be suggested that the S. persica content of gallic acid
(10), deoxy ellagic acid (3), methoxy ellagic acid (6), sulphated hexosyl polyphenols (10),
O-benzyl hexosyl sulphate (14), phenolic acid derivatives (16, C15 H22 O5 ), di-O-methyl ellagic acid (17), coumaric acid (19), ferulic acid (22), methoxy flavanone hexosyl rhamnoside
(23) and caffeic acid conjugate (24), representing 5% of the identified compounds of SPEAF,
may contribute to observed anti-inflammatory activities. In addition, the major fatty acids
identified were palmitic acid (4.98%), which has anti-inflammatory effects on endothelial
cells (ECs) with TNF-α and counter endothelial dysfunction [55] and oleic acids (4.71%),
which is an anti-inflammatory fatty acid that plays a role in the activation of different
pathways of immune-competent cells [56]. The identified urea derivatives (10.5%, with
N,N0 -dibenzyl urea; 7.7%) showed promising anti-inflammatory activity (62–84% TNF-α
and 73–92% IL-6 inhibitory activity) at a concentration of 10 µM, with reference to standard
dexamethasone [57]. Moreover, in addition from having a reported potent bactericidal
activity against oral pathogens and MRSA [58], the detected sulphur compound, benzyl
isothiocyanate (8.7%), significantly attenuated TPA-enhanced hydrogen peroxide levels
and acted as an inhibitor of O2 generation in mouse skin [59].
Oxidative stress contributes to the pathology of ulcerogenesis. Conversely, antioxidants reduce cellular damages that arise as a consequence of the increased generation of
oxidative species [60]. The present study highlights the antioxidant activity of S. persica
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in tongue tissues and is supported by several studies [61–63]. Based on our phytochemical analyses of S. persica extract, antioxidant activity can be attributed to its polyphenol
(5%) [64] and fatty acid (23%) content [65]. Farag et al. (2018) examined the antioxidant
activities of S. persica ethanol extract and some isolated compounds called persicaline [66].
Essentially, antioxidants have been reported to play an important role in expediting wound
healing by reducing oral mucosa inflammation, thus decreasing the risk of developing precancerous lesions [67]. This provides further insight into the healing properties of S. persica.
This also supports observed anti-inflammation, as oxidative stress and inflammation are
interconnected. The generated ROS induces the activation of transcription factors, which
drive the expression of pro-inflammatory mediators, such as IL-6 and TGF-β [68].
Collagen, a key protein of the extracellular matrix produced by fibroblasts, is involved
in the healing of connective tissues [69]. The final stages of wound healing involve remodelling, which should result in the closure of wounds or ulcers. In this context, collagen and
hydroxyproline play an important role [70]. The results from this study indicated increased
hydroxyproline formation and Col1A1 mRNA expression in the S. persica-treated group
in comparison to untreated animals. In accordance with these findings, S. persica extract
has been reported to inhibit collagen degradation in demineralised dentin [71]. Moreover,
S. persica extract-laden collagen hybrid constructs showed enhanced periodontal tissue
regeneration [72], consistent with the ability of S. persica to enhance fibroblast proliferation
and viability [73]. This also supports the observed ability of S. persica to enhance angiogenesis, as evidenced by increased Ang-1 mRNA expression. In other words, collagen
deposition in wound tissues is associated with enhanced angiogenesis [74]. Angiogenesis
plays a key role in the wound-healing process and is involved in the migration, growth
and differentiation of ECs [75]. The ability of naturally occurring compounds has been
reviewed [76]. Our data are supported by the ability of flavonoids to boost angiogenesis
in non-cancerous tissues [77]. In conclusion, S. persica has a wide range of secondary
metabolites ameliorate acetic acid-induced tongue ulcers in rats. This can be attributed,
at least partly, to its anti-inflammatory, antioxidant, procollagen and angiogenic activities.
These findings provide support and validity for the use of S. persica as a traditional and
conventional treatment for oral disorders and validate its application in the treatment of
oral ulcers, which warrants further clinical studies.
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